Incoming Resources
- Qué hacer si ya no califica automáticamente para la Ayuda Adicional con los costos de la cobertura de recetas médicas de Medicare
- Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D
- Medicaid drug rebate program, inadequate oversight raises concerns about rebates paid to states : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Kathleen King
- Unit of measure Inconsistencies in the Medicaid prescription drug program
- Medicaid long-term care, information obtained by states about applicants' assets varies and may be insufficient : report to congressional requesters
- How inflated published prices affect drugs considered for the federal upper limit list
- Medicare and Medicaid, the 1965 and 1967 Social Security amendments
- Mental health and substance abuse services in Medicaid, 1995, Jeffrey A. Buck, Kay Miller
- One year later, Medicaid's response to systemic problems by the death of Deamonte Driver : hearing before the Subcommittee on Domestic Policy of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, February 14, 2008
- What to do if you no longer automatically qualify for extra help with Medicare prescription drug costs
- Medicaid home and community-based waivers, CMS should encourage states to conduct mortality reviews for individuals with developmental disabilities : report to the Ranking Member, Committee on Finance, U.S. Senate
- Centers for Medicare & Medicaid Services
- Recommendation followup memorandum report, CMS needs to do more to improve Medicaid children's utilization of preventive screening services
- Understanding cost sharing protections for American Indian and Alaska Natives in Medicaid, CHIP, and the Marketplace
- Enroll in Medicaid, for yourself, for your family, for your community
- Medicaid at-a-glance, 2005, a Medicaid information source
- Medicaid demonstration waivers, recent HHS approvals continue to raise cost and oversight concerns : report to congressional requesters